医学
皮肤病科
颧骨皮疹
黑棘皮病
皮疹
刺激性接触性皮炎
亚急性皮肤红斑狼疮
皮密莫司
局部类固醇
他克莫司
疾病
接触性皮炎
结缔组织病
糖尿病
病理
外科
自身免疫性疾病
过敏
免疫学
胰岛素抵抗
移植
抗体
抗核抗体
自身抗体
内分泌学
作者
Brian Z Rayala,Dean S. Morrell
出处
期刊:PubMed
日期:2017-02-01
卷期号:453: 18-25
被引量:2
摘要
Cutaneous adverse drug reactions are among the most common noninfectious rashes of childhood. Cutaneous adverse drug reactions are classified as morbilliform, urticarial, bullous, pustular, or psoriasiform. Atopic dermatitis is one of the most common inflammatory cutaneous eruptions, and is characterized by pruritus and flexural distribution. Emollients and topical corticosteroids are first-line therapies. Topical calcineurin inhibitors are second-line, steroid-sparing drugs for certain conditions, such as face and eyelid eczema. Systemic and immunologic conditions have mucocutaneous features, such as malar rash, discoid lupus, and photosensitivity in systemic lupus erythematosus; lip, oral, and extremity changes as well as polymorphous rash in Kawasaki disease; erythematous, scaly plaques in psoriasis; and xerosis and face, hand, and leg skin changes in type 1 diabetes. Genetic conditions that manifest as changes in skin pigmentation are important to recognize because of the thorough diagnostic evaluation they warrant, the often challenging interventions they necessitate, and the permanent disability that frequently accompanies them. These conditions include neurofibromatosis, LEOPARD syndrome, incontinentia pigmenti, congenital hemidysplasia with ichthyosiform erythroderma and limb defects syndrome, hypomelanosis of Ito, and acanthosis nigricans. Childhood dermatologic emergencies often are associated with infection and drugs and require early recognition and intervention.
科研通智能强力驱动
Strongly Powered by AbleSci AI